Senthil Sundaram
2020
In 2020, Senthil Sundaram earned a total compensation of $13.7M as Chief Executive Officer at Terns Pharmaceuticals.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $223,437 |
| Option Awards | $13,135,650 |
| Salary | $208,333 |
| Total | $13,717,420 |
Sundaram received $13.1M in option awards, accounting for 96% of the total pay in 2020.
Sundaram also received $150K in bonus, $223.4K in non-equity incentive plan and $208.3K in salary.
Rankings
In 2020, Senthil Sundaram's compensation ranked 492nd out of 13,090 executives tracked by ExecPay. In other words, Sundaram earned more than 96.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 492 out of 13,090 | 96th |
Division Manufacturing | 169 out of 5,624 | 97th |
Major group Chemicals And Allied Products | 58 out of 2,257 | 97th |
Industry group Drugs | 52 out of 1,957 | 97th |
Industry Pharmaceutical Preparations | 37 out of 1,462 | 98th |
Source: SEC filing on April 29, 2022.
Sundaram's colleagues
We found two more compensation records of executives who worked with Senthil Sundaram at Terns Pharmaceuticals in 2020.